# Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients

> **NCT00736229** · PHASE4 · COMPLETED · sponsor: **Saint Luke's Health System** · enrollment: 40 (actual)

## Conditions studied

- Hyperglycemia
- Acute Coronary Syndromes
- Myocardial Infarction

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT00736229
- **Lead sponsor:** Saint Luke's Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-06
- **Final completion:** 2012-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736229, "Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00736229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*